P1097A - TO# LDR 04 MOD 02 - Raltegravir Pharmacokinetics and Safety in Neonates01/01/2014 - 12/31/2020 (PI)
Johns Hopkins University NIH-NIAID
P1097A – TO# LDR 04 MOD 03 – Raltegravir Pharmacokinetics and Safety in Neon…..01/01/2014 - 12/31/2020 (PI)
Johns Hopkins University Merck
P1110 - TO# LDR 02 MOD 03 - Phase I Trial (Merck)01/01/2014 - 12/31/2020 (PI)
Johns Hopkins University NIH-NIAID
LOC-IMPAACT Leadership Group - IMPAACT 2023 Protocol Chair12/01/2018 - 11/30/2020 (PI)
Johns Hopkins University NIH-NIAID
LOC-IMPAACT Leadership Group - JHU P1097 and P111001/01/2014 - 11/30/2015 (PI)
Johns Hopkins University NIH-NIAID5 UM1 AI068632-09
IMPAACT Leadership Award: Chair, Protocol P109706/01/2012 - 12/31/2013 (PI)
Johns Hopkins University NIH-NIAID
IMPAACT Leadership: Vice Chair Pharmacy Resource Committee06/01/2012 - 12/31/2013 (PI)
Johns Hopkins University NIH-NIAID
IMPAACT Leadership: International Maternal Pediatric Adolescent AIDS Clinical Trials Group06/01/2011 - 05/31/2012 (PI)
Social & Scientific Systems Inc. NIH-NIAID
IMPAACT Leadership - P1097 Protocol Chair06/01/2011 - 05/31/2012 (PI)
Social & Scientific Systems Inc. NIH-NIAID
IMPAACT P109706/01/2010 - 05/31/2011 (PI)
Social & Scientific Systems Inc. NIH-NIAID